Export

EN
FR
Insulin (human, short-acting)
Essential medicine status
Section:
18. Medicines for endocrine disorders 18.5. Medicines for diabetes 18.5.1. Insulins
ATC codes: A10AC01
EMLc
Indication
Type 1 diabetes mellitus ICD11 code: 5A10
INN
Neutral insulin injection
Medicine type
Biological agent
List type
Core (EML)
(EMLc)
Additional notes
including quality-assured biosimilars
Formulations
Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution ; 100 IU per mL in 10 mL vial solution ; 100 IU per mL in 3 mL cartridge solution ; 100 IU per mL in 3 mL pre-filled pen solution
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1987 (TRS 770)
Changed in 1997 (TRS 882)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2023 (TRS 1049)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Insulin (human, short-acting)
DrugBank
Insulin (Insulin Human)
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the medicine description be updated to replace 'Insulin injection (soluble)' with 'Insulin (human, short-acting); - to modify the formulation description to better describe the available dosage forms.